Why Omada Health is finally prescribing Ozempic as TrumpRx slashes GLP-1 weight-loss drug costs

A billion-dollar diabetes company that's previously refused to write Ozempic prescriptions is now changing its tune — right as the drugs are about to get a lot cheaper. Omada Health, the chronic care startup that went public in June, said Thursday it would start prescribing GLP-1 medications for obesity. Until now, Omada has stayed out of the GLP-1 prescribing game, leaving those decisions up to patients' primary care providers.The company's timing was fortuitous. A few hours earlier, President Donald Trum ...